Slobodan Antić

2.0k total citations · 1 hit paper
33 papers, 1.1k citations indexed

About

Slobodan Antić is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Slobodan Antić has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Slobodan Antić's work include Diabetes Treatment and Management (10 papers), Metabolism, Diabetes, and Cancer (8 papers) and Diabetes Management and Research (4 papers). Slobodan Antić is often cited by papers focused on Diabetes Treatment and Management (10 papers), Metabolism, Diabetes, and Cancer (8 papers) and Diabetes Management and Research (4 papers). Slobodan Antić collaborates with scholars based in Serbia, Denmark and United Kingdom. Slobodan Antić's co-authors include Rafael Simó, Allan Vaag, David Russell‐Jones, Nebojša Lalić, O. Schmitz, Bipin Sethi, Marija Zdravković, Vladisav Stefanović, Predrag Vlahović and Gordana Lazarević and has published in prestigious journals such as Diabetologia, Diabetes/Metabolism Research and Reviews and Clinical Chemistry and Laboratory Medicine (CCLM).

In The Last Decade

Slobodan Antić

33 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

2009 688 citations David Russell‐Jones, Allan Vaag et al. Diabetologia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Slobodan Antić Serbia	14	859	464	295	201	159	33	1.1k
Toshihiko Shiraiwa Japan	18	733 0.9×	358 0.8×	461 1.6×	71 0.4×	100 0.6×	57	1.2k
Marta Seghieri Italy	15	534 0.6×	246 0.5×	298 1.0×	63 0.3×	125 0.8×	26	852
Robert W. Stout United Kingdom	15	674 0.8×	243 0.5×	239 0.8×	76 0.4×	223 1.4×	26	1.2k
H. U. Janka Germany	16	692 0.8×	161 0.3×	236 0.8×	57 0.3×	125 0.8×	30	1.1k
Hua Guo China	11	432 0.5×	181 0.4×	219 0.7×	89 0.4×	166 1.0×	47	964
Zin Zin Htike United Kingdom	10	804 0.9×	365 0.8×	283 1.0×	180 0.9×	103 0.6×	14	924
Adela Rovira Spain	18	332 0.4×	341 0.7×	201 0.7×	23 0.1×	166 1.0×	53	985
Y Ohkubo Japan	4	529 0.6×	149 0.3×	107 0.4×	66 0.3×	83 0.5×	9	731
Shalini M Krishnan Australia	8	202 0.2×	398 0.9×	134 0.5×	67 0.3×	120 0.8×	9	1.0k
Chenguang Li China	11	356 0.4×	258 0.6×	200 0.7×	46 0.2×	77 0.5×	21	741

Countries citing papers authored by Slobodan Antić

Since Specialization

Citations

This map shows the geographic impact of Slobodan Antić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Slobodan Antić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Slobodan Antić more than expected).

Fields of papers citing papers by Slobodan Antić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Slobodan Antić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Slobodan Antić. The network helps show where Slobodan Antić may publish in the future.

Co-authorship network of co-authors of Slobodan Antić

This figure shows the co-authorship network connecting the top 25 collaborators of Slobodan Antić. A scholar is included among the top collaborators of Slobodan Antić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Slobodan Antić. Slobodan Antić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pešić, Milica, Milan Radojković, Tatjana Jevtović−Stoimenov, et al.. (2018). Expression of prolactin receptors in the duodenum, kidneys and skeletal system during physiological and sulpiride-induced hyperprolactinaemia. Endocrine. 62(3). 681–691. 4 indexed citations

Pešić, Milica, et al.. (2014). Subclinical hypothyroidism: association with cardiovascular risk factors and components of metabolic syndrome. Biotechnology & Biotechnological Equipment. 29(1). 157–163. 22 indexed citations

Radenković, Saša, et al.. (2012). Insulin resistance and C reactive protein level. 15th International & 14th European Congress of Endocrinology. 29. 1 indexed citations

Obradović, Radmila, et al.. (2012). Low-Level Lasers as an Adjunct in Periodontal Therapy in Patients with Diabetes Mellitus. Diabetes Technology & Therapeutics. 14(9). 799–803. 30 indexed citations

Obradović, Radmila, Ljiljana Kesić, D. Mihailović, et al.. (2012). A histological evaluation of a low-level laser therapy as an adjunct to periodontal therapy in patients with diabetes mellitus. Lasers in Medical Science. 28(1). 19–24. 39 indexed citations

Mikić, Dragan, et al.. (2009). Biphasic insulin aspart 30: Better glycemic control than with premixed human insulin 30 in obese patients with Type 2 diabetes. Journal of Endocrinological Investigation. 32(1). 23–27. 24 indexed citations

Russell‐Jones, David, Allan Vaag, O. Schmitz, et al.. (2009). Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial. Diabetologia. 52(10). 2046–2055. 688 indexed citations breakdown →

Lazarević, Gordana, et al.. (2008). Effects of regular exercise on cardiovascular risk factors profile and oxidative stress in obese type 2 diabetic patients in regard to SCORE risk. Acta Cardiologica. 63(4). 485–491. 18 indexed citations

Lazarević, Gordana, et al.. (2008). PC-1 (ENPP1) K121Q polymorphism in overweight and obese type 2 diabetic coronary heart disease patients. Acta Cardiologica. 63(3). 323–330. 3 indexed citations

10.

Cvetković, Tatjana, Branka Mitić, Gordana Lazarević, et al.. (2008). Oxidative stress parameters as possible urine markers in patients with diabetic nephropathy. Journal of Diabetes and its Complications. 23(5). 337–342. 29 indexed citations

11.

Rajić, Milena, et al.. (2007). Thyroid blood flow and uptake of technetium-99m pertechnetate in Graves' disease.. PubMed. 9(3). 173–6. 4 indexed citations

12.

Lalić, Nebojša, Dušan Micić, Slobodan Antić, et al.. (2007). Effect of biphasic insulin aspart on glucose and lipid control in patients with Type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy. 8(17). 2895–2901. 3 indexed citations

13.

Lazarević, Gordana, et al.. (2007). Effects of Aerobic Exercise on Microalbuminuria and Enzymuria in Type 2 Diabetic Patients. Renal Failure. 29(2). 199–205. 42 indexed citations

14.

Rajić, Milena, Slobodan Ilić, Marina Vlajković, et al.. (2007). Radionuclide Staging of Renal Function in Type 1 Diabetes Mellitus. Renal Failure. 29(6). 685–691. 4 indexed citations

15.

Pešić, Milica, et al.. (2007). Cardiovascular risk factors in patients with subclinical hypothyroidism. Vojnosanitetski pregled. 64(11). 749–752. 7 indexed citations

16.

Lazarević, Gordana, Slobodan Antić, Tatjana Cvetković, et al.. (2006). A physical activity programme and its effects on insulin resistance and oxidative defense in obese male patients with type 2 diabetes mellitus. Diabetes & Metabolism. 32(6). 583–590. 54 indexed citations

17.

Stefanović, Vladisav, et al.. (2006). Lymphocyte ecto-5′-nucleotidase in obese type 2 diabetic patients treated with gliclazide. Diabetes & Metabolism. 32(2). 166–170. 3 indexed citations

18.

Antić, Slobodan, et al.. (2003). Urinary PC-1 activity in patients with type 1 diabetes mellitus. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 40(3). 235–238. 4 indexed citations

19.

Antić, Slobodan, et al.. (2001). Monotherapy with Metformin: Does It Improve Hypoxia in Type 2 Diabetic Patients?. Clinical Chemistry and Laboratory Medicine (CCLM). 39(9). 818–21. 34 indexed citations

20.

Stefanović, Vladisav, et al.. (1999). Reversal of increased lymphocyte PC-1 activity in patients with Type 2 diabetes treated with metformin. Diabetes/Metabolism Research and Reviews. 15(6). 400–404. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact